IRIS - Res&Arch Institutional Research Information System - Research & Archive

PASQUALUCCI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.087
AS - Asia 2.371
EU - Europa 2.315
SA - Sud America 366
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.185
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.026
SG - Singapore 988
IE - Irlanda 482
UA - Ucraina 454
HK - Hong Kong 421
IT - Italia 344
BR - Brasile 315
VN - Vietnam 305
CN - Cina 278
RU - Federazione Russa 272
SE - Svezia 271
KR - Corea 186
DE - Germania 143
FI - Finlandia 117
GB - Regno Unito 66
TR - Turchia 66
CA - Canada 34
FR - Francia 33
IN - India 28
PL - Polonia 26
AR - Argentina 21
AT - Austria 20
BE - Belgio 20
CH - Svizzera 18
MX - Messico 18
ZA - Sudafrica 16
BD - Bangladesh 14
IQ - Iraq 14
NL - Olanda 13
EC - Ecuador 12
ES - Italia 12
JP - Giappone 11
LB - Libano 10
UZ - Uzbekistan 10
ID - Indonesia 8
GR - Grecia 7
MA - Marocco 7
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
EG - Egitto 4
PK - Pakistan 4
PY - Paraguay 4
VE - Venezuela 4
BG - Bulgaria 3
CO - Colombia 3
GE - Georgia 3
PA - Panama 3
PE - Perù 3
TH - Thailandia 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
EU - Europa 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
NG - Nigeria 2
RO - Romania 2
SN - Senegal 2
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NP - Nepal 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 8.185
Salva come PNG Salva come JPEG
Città #
Singapore 645
Dublin 482
Chandler 443
Hong Kong 421
Jacksonville 252
San Mateo 251
Boardman 203
Dong Ket 202
Seoul 186
Ashburn 145
Santa Clara 144
Altamura 135
Perugia 123
Medford 116
Princeton 113
Ann Arbor 97
Moscow 93
Lawrence 90
Wilmington 85
Andover 66
Izmir 56
Beijing 55
New York 46
Des Moines 42
Saint Petersburg 38
Los Angeles 36
Ho Chi Minh City 32
Piscataway 29
Norwalk 26
São Paulo 25
Hanoi 22
Brussels 20
Helsinki 20
The Dalles 20
Falls Church 19
Dallas 18
Nuremberg 18
Belo Horizonte 17
Woodbridge 17
Amelia 16
Munich 14
Stockholm 14
West Jordan 14
Johannesburg 13
Chicago 12
Montreal 12
Phoenix 12
San Paolo di Civitate 12
Warsaw 12
Frankfurt am Main 11
Rio de Janeiro 11
Shanghai 11
Tokyo 11
Dearborn 10
Brooklyn 9
Haiphong 9
Chennai 8
Columbus 8
Denver 8
Hefei 8
Houston 8
London 8
Mexico City 8
Redwood City 8
Vienna 8
Guangzhou 7
Nanning 7
Orem 7
Den Haag 6
Porto Alegre 6
Redmond 6
Secaucus 6
Toronto 6
Atlanta 5
Boston 5
Dhaka 5
Frankfurt Am Main 5
Guayaquil 5
Istanbul 5
Jamaica 5
Philadelphia 5
Tashkent 5
Turku 5
Asunción 4
Auburn Hills 4
Belém 4
Biên Hòa 4
Brasília 4
Campo Grande 4
Guarulhos 4
Jakarta 4
Mumbai 4
Rio Claro 4
San Diego 4
San Francisco 4
Santa Fe 4
Amsterdam 3
Athens 3
Barcelona 3
Basra 3
Totale 5.288
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 156
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. 131
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 122
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 118
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. 117
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence 115
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 115
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 114
Analysis of the coding genome of diffuse large B cell lymphoma 111
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 110
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 109
AID is required for germinal center-derived lymphomagenesis. 104
Alterations of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 102
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. 101
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 99
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. 96
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 96
BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. 96
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. 95
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 93
B-cell receptor signaling derailed in lymphomas. 93
BRAF mutations in hairy-cell leukemia. 93
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. 92
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 92
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. 91
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 90
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 88
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. 88
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 87
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 86
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. 84
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. 83
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 83
Molecular pathogenesis of germinal center-derived B cell lymphomas 83
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. 81
Expression of the AID protein in normal and neoplastic B cells. 81
Hypermutation of multiple proto-oncogenes in B-cell Diffuse Large Cell Lymphomas 80
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 80
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 78
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 78
Targeted antibodies in the treatment of lymphomas. 76
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3ß inhibition 76
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma 76
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. 73
Pathology and Molecular Pathogenesis of DLBCL and Related Entities 72
Proto-oncogenes and Tumor Suppressor Genes in Hematopoietic Malignancies 71
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression 71
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. 69
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma 69
Follicular lymphoma dynamics 68
IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE ANTI-PROMYELOCYTIC LEUKEMIA (ANTI-PML) MONOCLONAL ANTIBODY PG-M3 68
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 68
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. 68
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization 68
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). 67
Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma 63
null 62
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 62
Molecular Genetics of Lymphoma 62
Repurposing Dasatinib for diffuse large B cell lymphoma. 62
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. 60
The genetics of nodal marginal zone lymphoma 60
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. 59
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. 58
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis 58
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 57
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. 57
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 57
Molecular Biology of Lymphoma 57
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. 56
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 56
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. 56
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome 55
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 55
Towards patient-based cancer therapeutics. 54
Molecular Biology of Lymphoma 54
Genetics of follicular lymphoma transformation. 54
Dissecting KMT2D missense mutations in Kabuki syndrome patients 54
Genomic profiling for clinical decision making in lymphoid neoplasms 53
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. 53
Genetics of diffuse large b-cell lymphoma 53
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis 53
Emerging epigenetic-modulating therapies in lymphoma 53
Molecular pathogenesis of B cell malignancy: the role of BCL-6. 52
Molecular pathogenesis of diffuse large B-cell lymphoma 52
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program 51
New approaches to lymphoma diagnosis. 51
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 51
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells 50
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 49
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. 49
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. 49
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 49
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. 49
Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL 48
Immunotoxin therapy of hematological malignancies. 48
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. 48
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. 48
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. 47
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas 46
Totale 7.401
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021557 0 0 0 0 0 44 68 6 113 28 76 222
2021/2022961 24 180 14 61 43 11 14 291 16 35 124 148
2022/20231.607 125 313 23 144 98 170 1 72 604 5 41 11
2023/2024671 33 51 31 11 4 5 174 9 96 31 79 147
2024/20251.593 102 175 20 49 317 51 37 89 323 115 173 142
2025/20261.656 305 226 208 347 393 177 0 0 0 0 0 0
Totale 8.414